Congress approves biomedical bill as leaders eye adjournment

December 7, 2016 by Alan Fram And Andrew Taylor
Senate Majority Leader Mitch McConnell of Ky. speaks to the media after the Republican policy luncheon on Capitol Hill in Washington, Tuesday, Dec. 6, 2016. From left are, Sen. Roger Wicker, R-Miss., Sen. John Barrasso, R-Wyo., McConnell, Sen. Roy Blunt, R-Mo., Sen. John Thune, R-S.D., and Senate Majority Whip John Cornyn of Texas. (AP Photo/Sait Serkan Gurbuz)

With an atypical burst of bipartisanship, the Senate shipped legislation to President Barack Obama on Wednesday lowering hurdles for government drug approvals as the 114th Congress bumped toward the end of a two-year run highlighted by upheaval and stalemate.

A week after the House easily approved the biomedical bill, senators passed it by a similarly overwhelming 94-5 margin. That was testament to a package that plans spending $6.3 billion over the next decade on popular efforts like cancer research and battling drug addiction.

"This is a reminder of what we can do when we look out for one another," Obama said in a written statement that promised his signature. Referring to families that have endured losses to cancer, Alzheimer's and drug abuse, he added, "Their heartbreak is real, and so we have a responsibility to respond with real solutions. This bill will make a big difference."

"This is an opportunity we cannot miss, and we're not going to miss it," said Sen. Lamar Alexander, R-Tenn., chairman of the Senate health committee.

Before adjournment, which leaders targeted for later this week, lawmakers were also tackling bills financing government agencies into late April, mapping Pentagon programs and planning water projects.

In a chamber where senators can flash barely concealed animosity, they showed their more gracious side with speeches lauding departing colleagues including Sens. Barbara Mikulski, D-Md., and Kelly Ayotte, R-N.H. The Senate floor was also the stage for accolades to departing Vice President Joe Biden, who served 36 years as a Democratic senator from Delaware.

"You've been a real friend, you've been a trusted partner and it's been an honor to serve with you," Senate Majority Leader Mitch McConnell, R-Ky., said to Biden, who presided over the tribute.

Senate Minority Leader Harry Reid of Nev., flanked by Senate Minority Whip Richard Durbin of Ill., left, and Senate Minority Leader-elect Charles Schumer of N.Y., answers questions from the media after the Democratic policy luncheon on Capitol Hill in Washington, Tuesday, Dec. 6, 2016. (AP Photo/Sait Serkan Gurbuz)

That comradery was also reflected in the biomedical bill, which included a planned $1.8 billion for . Biden, whose 46-year-old son Beau succumbed to the disease last year, has championed such work.

That bill, which also takes steps to sharpen federal mental health programs, drew praise from scores of pharmaceutical, device and other medical industry associations and from numerous patients' groups.

It was opposed by consumer organizations and liberals who said the measure's shortcuts for Food and Drug Administration approvals would endanger consumers and represented a sellout to drug makers. They also complained that it will take later legislation for Congress to provide the funds the bill envisions.

"Congress should not have had to jeopardize patient safety to increase medical research funding," said Michael Carome, director of Public Citizen's Health Research Group.

The drug bill was a cooperative capstone to a Congress that has seen its share of tumult.

A conservative rebellion booted Speaker John Boehner, R-Ohio, from office last year. Democrats staged an overnight sit-in on the House floor protesting the GOP-led Congress' inaction on gun control. Senate Republicans refused to let Obama fill a Supreme Court vacancy after Justice Antonin Scalia died last February.

The two parties gridlocked over easing trade barriers with Pacific Ocean nations and revamping criminal justice statutes, and in a prelude to next year's battles, Obama vetoed a repeal of his health care law. It took months for lawmakers to approve money to combat the Zika virus.

In this Nov. 14, 2016 file photo, members of the New York Police Department's counterterrorism unit guard Trump Tower in New York. New York City's mayor and other Democratic officials say Congress is coming up far too short in proposing to reimburse the city $7 million for protecting Trump Tower. Mayor Bill de Blasio said Wednesday, Dec. 7, 2016, that New York City taxpayers "should not be on the hook for 80 percent of the national bill" to protect Republican President-elect Donald Trump and his family. (AP Photo/Mark Lennihan, File)

Congress did extend dozens of minor tax breaks for individuals and businesses, reshaped how Medicare reimburses doctors and rewrote federal education and transportation programs.

Before adjourning, lawmakers still needed to approve government-wide spending legislation. It contained money to keep agencies functioning into next spring, when the new President Donald Trump and GOP-run Congress would make final budget decisions.

It included $4.1 billion in disaster aid for Louisiana and other states, $170 million to help Flint, Michigan, rebuild its lead-poisoned water system and other funds for U.S. anti-terrorism operations overseas. It also contained a provision to help former Gen. James Mattis become Trump's Defense secretary by making it easier for Congress next year to waive the required seven-year wait before military retirees can head the Pentagon.

No one was expecting the bill to fail—which would produce a Friday night government shutdown—but there were lingering disputes to resolve.

These included complaints from coal country lawmakers that the measure insufficiently extended health care benefits for 16,000 retired mine workers, whose coverage is slated to end Dec. 31. Democrats were unhappy the bill provided just $7 million of the $35 million the Obama administration requested to beef up security in midtown Manhattan, home to President-elect Donald Trump.

By 92-7, the Senate gave preliminary approval to a defense policy bill that would block Obama from his goal of shuttering the military prison at Guantanamo Bay, Cuba.

A $558-million water-projects bill was in jeopardy, due to a fight over spending for California that pitted agricultural against environmental interests.

Explore further: Senate votes to move bill speeding federal drug OKs

Related Stories

Senate votes to move bill speeding federal drug OKs

December 5, 2016
The Senate moved Monday toward removing the last hurdles to legislation bolstering disease research and simplifying the government's pathway for pharmaceutical and medical device approvals as a Congress marked by frequent ...

House OKs bill bolstering medical research, drug approvals

November 30, 2016
The House easily approved a sweeping biomedical bill Wednesday that would help drug and medical device companies win swifter government approval of their products, boost disease research and drug-abuse spending and revamp ...

Senate approves bipartisan bill bolstering anti-drug efforts

March 10, 2016
The Senate paused Thursday from its nasty partisan clash over the Supreme Court vacancy and easily approved election-year legislation reinforcing government efforts against heroin and the abuse of opioid painkillers.

Congress struggles to finish Zika aid, prevent shutdown (Update)

September 19, 2016
Congressional negotiators on Monday pressed to wrap up a must-do spending bill to prevent an election-season government shutdown and finally provide money to battle the threat of the Zika virus, but numerous sticking points ...

Senate blocks Zika funding for third time

September 7, 2016
US Senate Democrats blocked a $1.1 billion bill to combat the Zika virus for a third time Tuesday after Republicans inserted provisions that would end funding for a major abortion provider.

Senate GOP setting up 'Obamacare' vote on highway bill

July 24, 2015
Senate Republican leaders announced plans Friday to use a must-pass highway bill to try to overturn President Barack Obama's health care law, in the latest GOP assault on "Obamacare."

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.